ClinicalTrials.Veeva

Menu

Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care

Florida International University (FIU) logo

Florida International University (FIU)

Status

Invitation-only

Conditions

Alzheimer Disease
Caregiver
Neurocognitive Disorders

Treatments

Other: My PATI ( Person Assisted Touchscreen Interface)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04571502
NIH Award R01AG068572 (Other Grant/Funding Number)
R01AG068572

Details and patient eligibility

About

Alzheimer's disease and related dementias (ADRD) are leading causes of disability and often result in communication deficits of the person with dementia (PWD) that can complicate ADRD caregiving and clinical care. The research team will work with stakeholders to develop and design a personalized Assistive and Alternative Communication (AAC) device that relies on information technology (IT) and touchscreens to promote communication and personhood for PWD about their care preferences and experiences. This study will integrate the AAC into an existing health IT intervention that already facilitates clinical communication between caregivers and providers of PWD. A clinical trial will be conducted to evaluate outcomes of 58 dyads (PWD/caregivers) and their health care provider utilizing the My PATI (My Person Assisted Touchscreen Interface)intervention as an adjunct to care and care giving for 6 months.

Full description

The target enrollment for the clinical trial is 58 dyads of caregivers and people with dementia (PWD), where 58 unique dyads of caregivers/PWD will participate. The team plans to enroll a total of 58 dyads across two participating clinical sites. Participants will be randomly assigned to either the full intervention or a control condition for a period of 6 months, where they will be asked to communicate clinical and other relevant information with one another as part of regular caregiving and clinical care activities. Several psychosocial outcome variables for providers, caregivers, and PWD will be assessed. We will compare outcomes based on group assignment and different amounts and patterns of use of the MyPATI (e.g., minimal/non-users versus frequent users). The primary outcome variables are quality of life for caregivers and PWD. The research team will recruit an estimated 15 healthcare providers across both sites at the end of study to assess their experience with My PATI using open and closed ended queries.

Enrollment

58 estimated patients

Sex

All

Ages

21 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Caregivers:

  • Regular access to the internet (via computer or smartphone) and telephone
  • 21 years-old or older
  • Providing caregiving activities (Activities of Daily Living and/or Instrumental Activities of Daily Living) for an average of 2 hours or more per day of direct assistance or supervision for a person with ADRD
  • Speak and understand English or Spanish.

Care Recipient:

  • 60 years or older
  • Speak and understand English or Spanish
  • Have an established diagnosis of a Neurocognitive Disorder (Alzheimer's disease, vascular dementia, frontotemporal dementia, Lewy body dementia or Parkinson's disease dementia)
  • Receive a score on the Mini Mental Status Exam of less than 24
  • Be able to complete the eligibility vision screen.

Healthcare Providers:

* Provide ongoing healthcare and support services to PWD and their families.

Exclusion Criteria

Caregivers:

  • Provide care to a PWD living in an assisted living facility or nursing home
  • Plan for the PWD to be placed in a long-term care facility during the study period
  • Plan to end their role as caregiver within 6 months of study enrollment
  • Have their own major medical conditions affecting independent functioning (e.g. illness or disability) or cognitive impairment
  • Do not speak and read English or Spanish
  • Have known active suicidal ideation

Care Recipients:

  • Significant visual or hearing impairment (with supports)
  • Known active suicidal ideation
  • Schizophrenia diagnosis

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

58 participants in 2 patient groups

Full Intervention
Experimental group
Description:
Dyads (caregiver, PWD) randomly assigned to the experimental arm will have access to the newly developed My PATI app. Providers' will receive information via the app.
Treatment:
Other: My PATI ( Person Assisted Touchscreen Interface)
Usual Care
No Intervention group
Description:
Dyads (caregiver, PWD) randomly assigned to the usual care condition will receive usual care from the memory clinic.

Trial contacts and locations

2

Loading...

Central trial contact

Nicole Ruggiano, PhD, MSW; Ellen L Brown, EdD,RN,FAAN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems